Can doctors directly assess plaque in blood vessels to better predict heart attack risk, rather than relying solely on traditional lipid profiles? Can liver enlargement be evaluated beyond a physical exam and a standard CT scan? Increasingly, the answer to both is yes—thanks to advances in imaging, analytics, and artificial intelligence that are reshaping preventive healthcare.

At the forefront of this shift is Fujifilm Corporation, the iconic Japanese multinational known for innovations spanning photographic film, X-ray systems, digital cameras, and cutting-edge medical imaging. In India, Fujifilm’s collaboration with Kerala's Dr Kutty’s Healthcare group —through their joint initiative ‘Nura’—is accelerating AI-assisted preventive health screening with ambitious expansion plans.

“We are planning to set up 100 centres across the globe by 2030, and out of this, about 30 will be in India,” said Masaharu Morita, Founder and Program Director at Nura and New Business Head of Fujifilm’s Healthcare domain, in an interaction with Fortune India.

Launched in 2021 with its first centre in Bengaluru, Nura now operates additional facilities in Delhi, Mumbai, Hyderabad, and Chennai. Globally, the network has expanded to 12 centres across Vietnam, Mongolia, Thailand, the UAE, and South Africa. New sites are in the pipeline in South Africa, Kenya, Egypt, Iraq, Lebanon, the UK, Sri Lanka, the Philippines, and Malaysia. In India, Pune and Ahmedabad are likely to host upcoming centres.

Earlier this year, Fujifilm inaugurated a Global Innovation Centre in Kozhikode, Kerala, as a global capability centre focused on workforce training and AI development. The facility deploys Fujifilm’s medical devices and AI platforms to support diagnostic decision-making and deliver high-quality, Japanese-style health screening services to residents and corporate employees. It also functions as a training hub for medical staff—doctors, radiological technologists, and nurses—working across Nura locations, and serves as a centralised remote interpretation centre for images acquired within India. Fujifilm is leveraging the Kozhikode hub as a development base for AI diagnostic support technologies, and the centre already employs nearly 200 people.

Each Nura centre, with an investment of over Rs 2 crore, is equipped with Fujifilm’s latest medical imaging systems—including CT scanners and mammography—alongside AI-driven medical IT designed to help clinicians screen for cancers and lifestyle-related diseases with greater precision and efficiency. By integrating advanced imaging with algorithmic analysis, the model aims to detect conditions earlier and tailor follow-up care more effectively than conventional screening pathways.